Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background—: Experimental studies suggest that visceral adiposity and adipose tissue dysfunction play a central role in obesity-related cardiometabolic complications. Impaired angiogenesis in fat has been implicated in the development of adipose tissue hypoxia, capillary rarefaction, inflammation, and metabolic dysregulation, but pathophysiological mechanisms remain unknown. In this study, we examined the role of a novel antiangiogenic isoform of vascular endothelial growth factor-A (VEGF-A), VEGF-A 165 b, in human obesity. Methods and Results—: We biopsied paired subcutaneous and visceral adipose tissue in 40 obese subjects (body mass index, 45±8 kg/m 2 ; age, 45±11 years) during bariatric surgery and characterized depot-specific adipose tissue angiogenic capacity using an established ex vivo assay. Visceral adipose tissue exhibited significantly blunted angiogenic growth compared with subcutaneous fat ( P <0.001) that was associated with marked tissue upregulation of VEGF-A 165 b ( P =0.004). The extent of VEGF-A 165 b expression correlated negatively with angiogenic growth ( r =−0.6, P =0.006). Although recombinant VEGF-A 165 b significantly impaired angiogenesis, targeted inhibition of VEGF-A 165 b with neutralizing antibody stimulated fat pad neovascularization and restored VEGF receptor activation. Blood levels of VEGF-A 165 b were significantly higher in obese subjects compared with lean control subjects ( P =0.02), and surgical weight loss induced a marked decline in serumVEGF-A 165 b ( P =0.003). Conclusions—: We demonstrate that impaired adipose tissue angiogenesis is associated with overexpression of a novel antiangiogenic factor, VEGF-A 165 b, that may play a pathogenic role in human adiposopathy. Moreover, systemic upregulation of VEGF-A 165 b in circulating blood may have wider-ranging implications beyond the adipose milieu. VEGF-A 165 b may represent a novel area of investigation to gain further understanding of mechanisms that modulate the cardiometabolic consequences of obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Adipose Tissue Oxygenation in Human Obesity
Pasarica, M., Sereda, O. R., Redman, L. M., Albarado, D. C., Hymel, D. T., Roan, L. E., Rood, J. C., Burk, D. H., & Smith, S. R. (2009) · Diabetes · doi:10.2337/db08-1098 · Cited by 786
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
Woolard, J., Wang, W.-Y., Bevan, H. S., Qiu, Y., Morbidelli, L., Pritchard-Jones, R. O., Cui, T.-G., Sugiono, M., Waine, E., Perrin, R., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0934 · Cited by 451
Self-citationZhang, Q.-X., Magovern, C. J., Mack, C. A., Budenbender, K. T., Ko, W., & Rosengart, T. K. (1997) · Journal of Surgical Research · doi:10.1006/jsre.1996.4983 · Cited by 365
Gealekman, O., Guseva, N., Hartigan, C., Apotheker, S., Gorgoglione, M., Gurav, K., Tran, K.-V., Straubhaar, J., Nicoloro, S., Czech, M. P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.970145 · Cited by 346 · cited 3×
“Fat biopsy samples freshly collected during bariatric surgery were immediately placed in sterile endothelial cell basal media-2 (Lonza), and angiogenesis studies were performed by previously published methods.(7) Briefly, fat pads were finely minced with scissors and enzymatically digested with 1 mg/mL collagenase typ…”
MethodResultInfluentialAngiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice
Bråkenhielm, E., Cao, R., Gao, B., Angelin, B., Cannon, B., Parini, P., & Cao, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000132745.76882.70 · Cited by 326 · cited 1×
“combat obesity with antiangiogenic interventions have failed to confer any metabolic benefit.(3,24) Rather, angiogenic insuffi-”
BackgroundVillaret, A., Galitzky, J., Decaunes, P., Estève, D., Marques, M.-A., Sengenès, C., Chiotasso, P., Tchkonia, T., Lafontan, M., Kirkland, J. L., et al. (2010) · Diabetes · doi:10.2337/db10-0398 · Cited by 282
Cited by
Adipose-tissue plasticity in health and disease
Sakers, A., De Siqueira, M. K., Seale, P., & Villanueva, C. J. (2022) · Cell · doi:10.1016/j.cell.2021.12.016 · Cited by 1,026
Fuster, J. J., Ouchi, N., Gokce, N., & Walsh, K. (2016) · Circulation Research · doi:10.1161/circresaha.115.306885 · Cited by 664
Self-citationImpaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A., & Smith, U. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2017 · Cited by 462
Vaccarino, V., Badimon, L., Bremner, J. D., Cenko, E., Cubedo, J., Dorobantu, M., Duncker, D. J., Koller, A., Manfrini, O., Milicic, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy913 · Cited by 404
Targeting obesity and diabetes to treat heart failure with preserved ejection fraction
Altara, R., Giordano, M., Nordén, E. S., Cataliotti, A., Kurdi, M., Bajestani, S. N., & Booz, G. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00160 · Cited by 61
“Atrial natriuretic peptide(31-67) inhibits Na+ transport in rabbit inner medullary collecting duct cells.”
Background
Metadata
- Authors
- Ngo, D. T. M., Farb, M. G., Kikuchi, R., Karki, S., Tiwari, S., Bigornia, S. J., Bates, D. O., LaValley, M. P., Hamburg, N. M., Vita, J. A., Hess, D. T., Walsh, K., & Gokce, N.
- Venue
- Circulation
- Published
- 2014-09-23
- Volume
- 130
- Issue
- 13
- Pages
- 1072-1080
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2143726472
- Cited by
- 81
- References
- 6
- FWCI
- 4.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.